August 10, 2023 US FDA approves Johnson & Johnson’s blood cancer therapy (Reuters) -Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer. The therapy, talquetamab-tgvs […]
August 10, 2023 US FDA approves Johnson & Johnson’s blood cancer therapy (Reuters) -Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer. The therapy, talquetamab-tgvs […]
